Literature DB >> 20189352

AHRQ series commentary 1: rating the evidence in comparative effectiveness reviews.

Yngve Falck-Ytter1, Holger Schünemann, Gordon Guyatt.   

Abstract

Mesh：

Year:  2010        PMID： 20189352     DOI： 10.1016/j.jclinepi.2010.01.003

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN： 0895-4356            Impact factor:   6.437


× No keyword cloud information.
  6 in total

Review 1.  Evidence-based review of interventions for medically at-risk older drivers.

Authors:  Sherrilene Classen; Miriam Monahan; Beth Auten; Abraham Yarney
Journal:  Am J Occup Ther       Date:  2014 Jul-Aug

2.  Ezetimibe-Statin Combination Therapy.

Authors:  Barbara Nußbaumer; Anna Glechner; Angela Kaminski-Hartenthaler; Peter Mahlknecht; Gerald Gartlehner
Journal:  Dtsch Arztebl Int       Date:  2016-07-01       Impact factor: 5.594

Review 3.  Vitamin D deficiency as a risk factor for dementia: a systematic review and meta-analysis.

Authors:  Isolde Sommer; Ursula Griebler; Christina Kien; Stefanie Auer; Irma Klerings; Renate Hammer; Peter Holzer; Gerald Gartlehner
Journal:  BMC Geriatr       Date:  2017-01-13       Impact factor: 3.921

4.  Can behavioural change interventions improve self-efficacy and exercise adherence among people with Parkinson's? A systematic review protocol.

Authors:  Leanne Ahern; Prof Suzanne Timmons; Prof Sarah E Lamb; Dr Ruth McCullagh
Journal:  HRB Open Res       Date:  2022-08-22

5.  How do systematic reviews incorporate risk of bias assessments into the synthesis of evidence? A methodological study.

Authors:  Srinivasa Vittal Katikireddi; Matt Egan; Mark Petticrew
Journal:  J Epidemiol Community Health       Date:  2014-12-06       Impact factor: 3.710

6.  Impact of timing of surgery in elderly hip fracture patients: a systematic review and meta-analysis.

Authors:  Thomas Klestil; Christoph Röder; Christoph Stotter; Birgit Winkler; Stefan Nehrer; Martin Lutz; Irma Klerings; Gernot Wagner; Gerald Gartlehner; Barbara Nussbaumer-Streit
Journal:  Sci Rep       Date:  2018-09-17       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.